Global Companion Diagnostics Market to reach a market size of $6.5 billion by 2025 - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Global Companion Diagnostics Market, published by KBV research, The Global Companion Diagnostics Market size is expected to reach $6.5 billion by 2025, rising at a market growth of 19.9% CAGR during the forecast period.

The Polymerase Chain Reaction (PCR) market dominated the Global Companion Diagnostics Market by Technology in 2018, growing at a CAGR of 20.3% during the forecast period. The Immunohistochemistry market is expected to witness a CAGR of 19.1% during (2019 - 2025).

The Oncology market dominated the Global Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 21.1 % during the forecast period. The Neurology market is expected to witness a CAGR of 18.3% during (2019 - 2025).

The North America market dominated the Global Lung Cancer Companion Diagnostics by Region in 2018, growing at a CAGR of 21.7 % during the forecast period. The Europe market is expected to witness a CAGR of 19.9% during (2019 - 2025). Additionally, The Asia Pacific market is expected to witness a CAGR of 23.5% during (2019 - 2025).

Full Report:https://www.kbvresearch.com/companion-diagnostics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.

Global Companion Diagnostics Market Segmentation

By Technology

  • Immunohistochemistry
  • Polymerase chain reaction (PCR)
  • Next generation sequencing (NGS)
  • In Situ Hybridization and
  • Other Technology

By Indication

  • Oncology
  • Neurology and
  • Other Indications

By Cancer Type

  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Blood Cancer and
  • Other Cancer Type

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Australia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Agilent Technologies, Inc.
  • Almac Group
  • ARUP Laboratories, Inc.
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.
  • Novartis AG
  • Illumina, Inc.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Companion Diagnostics Market Related Reports:

North America Market

Europe Market

Asia Pacific Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.